Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6030957 | NeuroImage | 2013 | 16 Pages |
Abstract
This study represents the first investigation of the test-retest reliability of the BOLD phMRI response to acute ketamine challenge. All models tested were effective at describing the ketamine response although the design matrix associated with the highest reliability may represent a robust and well-characterised ketamine phMRI assay more suitable for repeated-measures designs. This ketamine assay is applicable as a model of neurotransmitter dysfunction suitable as a pharmacodynamic imaging tool to test and validate modulatory interventions, as a model of NMDA hypofunction in psychiatric disorders, and may be adapted to understand potential antidepressant and analgesic effects of NMDAR antagonists.
Related Topics
Life Sciences
Neuroscience
Cognitive Neuroscience
Authors
S. De Simoni, A.J. Schwarz, O.G. O'Daly, A.F. Marquand, C. Brittain, C. Gonzales, S. Stephenson, S.C.R. Williams, M.A. Mehta,